Treating Cancer: A Changing Paradigm

Ravi Vij, MD

Video Categories: Hematological Malignancies

Dr. Vij delves into the role of bioinformatics in identifying targets for drug development.
June 16, 2015

The Biomarker: Melanoma

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.

October 6, 2014

Managing and Navigating Patients with Polycythemia Vera

Emily A. Knight, RN of the Mayo Clinic in Scottsdale, AZ, describes issues faced in managing and navigating patients with polycythemia Supported through funding from Incyte